alrestatin has been researched along with isodibut in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hung, DT; Lee, K; Mekalanos, JJ; Pierson, E; Shakhnovich, EA | 1 |
1 other study(ies) available for alrestatin and isodibut
Article | Year |
---|---|
Virstatin inhibits dimerization of the transcriptional activator ToxT.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Butyrates; Dimerization; Dose-Response Relationship, Drug; Naphthalenes; Naphthalimides; Promoter Regions, Genetic; Protein Binding; Trans-Activators; Transcription Factors; Vibrio cholerae | 2007 |